Orange Book product · Brand (NDA)
CEFTAZIDIME IN DEXTROSE CONTAINER
CEFTAZIDIME
At a glance
Jun 13, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 13, 2011
15 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFTAZIDIME
Strength
EQ 1GM BASE
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 050823
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1990CEPTAZBrand (NDA)
NDA 050646 · GLAXOSMITHKLINE
- 1985FORTAZBrand (NDA)
NDA 050578 · PAI HOLDINGS PHARM
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065481 · AUROBINDO PHARMA LTD
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065482 · AUROBINDO PHARMA LTD
- 2008CEFTAZIDIMEGeneric (ANDA)
ANDA 065196 · WOCKHARDT
- 1995PENTACEFGeneric (ANDA)
ANDA 063322 · GLAXOSMITHKLINE
- 1993TAZICEFGeneric (ANDA)
ANDA 064032 · HOSPIRA
- 1992PENTACEFGeneric (ANDA)
ANDA 064006 · GLAXOSMITHKLINE
- 1992PENTACEFGeneric (ANDA)
ANDA 064008 · GLAXOSMITHKLINE
- 1986TAZIDIME IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062739 · LILLY
- 1986TAZICEFGeneric (ANDA)
ANDA 062662 · HOSPIRA
- 1985CEFTAZIDIMEGeneric (ANDA)
ANDA 062640 · ACS DOBFAR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
